326
panel
Corporations Striving for a Better Tomorrow
Company missions are no longer enough, with consumers wanting companies to play a broader role i
n society, addressing important topics such as health and wellness, sustainability, and social causes.
+ Read More
panel
Transforming the Health-Care Supply Chain for the Future
Once viewed as a complex logistics system, the health-care supply chain has become a global hot
topic.
+ Read More
panel
Revolutionizing Investment Models for Rare-Disease Research
New regulations and shifts to the economy have the potential to impact industry appetites and ri
sk tolerances for investing in therapies that serve smaller populations.
+ Read More
panel
Part 2: Creating an Equitable, Nutritious, Sustainable, and Resilient Food System
Food policymaking occupies the nexus between agriculture and health care policy by determining t
he affordability, accessibility, and availability of nutritious food within communities.
+ Read More
panel
CEO Placeholder
panel
The Spoken Word: What Can Our Speech Tell Us About Our Health and Well-Being?
Natural speech analysis can provide insight into cognitive and mental health across an array of
disorders from Alzheimer’s to schizophrenia.
+ Read More
panel
A Health System that Meets Patients Where They Are
Research has shown that when patients are engaged and have a role in making decisions related to
their health, they form a greater understanding and commitment to following care and treatment plans.
+ Read More
panel
Part 2: Strengthening Global Health Systems: Investing in Community Health Workers
Community health workers (CHWs) are a vital yet oft-overlooked aspect of public health systems,
providing a crucial link between front-line communities and formal healthcare systems.
+ Read More
panel
Will Digital Therapeutics Scale or Fail?
In 2021, digital therapeutics benefited from record-breaking investment, up 134 percent from the
previous year and topping out at nearly $9 billion.
+ Read More
panel
No Turning Back: Protecting the Progress for Biomedical Innovation
The COVID-19 pandemic forced remarkable collaboration and acceleration in biomedical R&D.